Scott Power
Stock Analyst at Morgans
(0.64)
# 3,840
Out of 4,345 analysts
216
Total ratings
38.7%
Success rate
-2.6%
Average return
Main Sectors:
Stocks Rated by Scott Power
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $0.77 → $0.79 | $0.665 | +18.80% | 9 | May 27, 2026 | |
| ASX: BB1 BlinkLab Limited | Maintained: Buy | $1.76 | $0.695 | +153.24% | 1 | May 15, 2026 | |
| ASX: PNV PolyNovo Limited | Maintained: Buy | $1.83 → $1.56 | $1.27 | +22.83% | 11 | May 7, 2026 | |
| ASX: IPD ImpediMed Limited | Maintained: Buy | $0.05 → $0.02 | $0.006 | +233.33% | 31 | May 5, 2026 | |
| ASX: MX1 Micro-X Limited | Maintained: Buy | $0.16 → $0.15 | $0.045 | +233.33% | 41 | May 4, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Maintained: Buy | $2.71 → $2.63 | $1.74 | +51.59% | 11 | Apr 29, 2026 | |
| ASX: TTX Tetratherix Limited | Maintained: Buy | $7.03 → $6.84 | $6.85 | -0.15% | 7 | Apr 24, 2026 | |
| NZE: EBO EBOS Group Limited | Maintained: Buy | $34.38 → $28.07 | $19.51 | +43.87% | 22 | Apr 23, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Upgraded: Buy | $3.39 → $3.36 | $2.86 | +17.48% | 8 | Apr 12, 2026 | |
| ASX: CBL Control Bionics Limited | Maintained: Hold | $0.85 → $0.05 | $0.055 | n/a | 8 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.43 → $5.32 | $3.21 | n/a | 18 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.55 | $0.305 | n/a | 18 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.09 → $1.20 | $0.70 | n/a | 19 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.33 → $1.89 | $6.46 | n/a | 12 | Dec 14, 2021 |
Aroa Biosurgery Limited
May 27, 2026
Maintained: Buy
Price Target: $0.77 → $0.79
Current: $0.665
Upside: +18.80%
BlinkLab Limited
May 15, 2026
Maintained: Buy
Price Target: $1.76
Current: $0.695
Upside: +153.24%
PolyNovo Limited
May 7, 2026
Maintained: Buy
Price Target: $1.83 → $1.56
Current: $1.27
Upside: +22.83%
ImpediMed Limited
May 5, 2026
Maintained: Buy
Price Target: $0.05 → $0.02
Current: $0.006
Upside: +233.33%
Micro-X Limited
May 4, 2026
Maintained: Buy
Price Target: $0.16 → $0.15
Current: $0.045
Upside: +233.33%
Imricor Medical Systems, Inc.
Apr 29, 2026
Maintained: Buy
Price Target: $2.71 → $2.63
Current: $1.74
Upside: +51.59%
Tetratherix Limited
Apr 24, 2026
Maintained: Buy
Price Target: $7.03 → $6.84
Current: $6.85
Upside: -0.15%
EBOS Group Limited
Apr 23, 2026
Maintained: Buy
Price Target: $34.38 → $28.07
Current: $19.51
Upside: +43.87%
Sigma Healthcare Limited
Apr 12, 2026
Upgraded: Buy
Price Target: $3.39 → $3.36
Current: $2.86
Upside: +17.48%
Control Bionics Limited
Jan 8, 2024
Maintained: Hold
Price Target: $0.85 → $0.05
Current: $0.055
Upside: n/a
Aug 23, 2023
Maintained: Buy
Price Target: $5.43 → $5.32
Current: $3.21
Upside: n/a
Feb 28, 2022
Maintained: Buy
Price Target: $1.55
Current: $0.305
Upside: n/a
Feb 18, 2022
Maintained: Buy
Price Target: $1.09 → $1.20
Current: $0.70
Upside: n/a
Dec 14, 2021
Downgraded: Hold
Price Target: $2.33 → $1.89
Current: $6.46
Upside: n/a